WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Interview: ITER directorInterview: ITER directorU.S. moon lander Peregrine completes rePolar Research and Climate Change exhibition held in Hong KongKobe Bryant's widow gifts sneakers from her late husband's Nike line to LA Dodgers as All2023 CIFTIS revitalizes ancient Beijing Central Axis through technologyChina sends 9 satellites from seaKentucky AD Barnhart: No comment on suit by former swimmers alleging sexual misconduct by exBaidu strongly denies rumor of link between its AI tool and China’s military researchNew plant species discovered in SW China
3.0481s , 5319.5625 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,International Investigation news portal